HER2-ResNet: A HER2 classification method based on deep residual network.
Journal:
Technology and health care : official journal of the European Society for Engineering and Medicine
Published Date:
Jan 1, 2022
Abstract
BACKGROUND: HER2 gene expression is one of the main reference indicators for breast cancer detection and treatment, and it is also an important target for tumor targeted therapy drug selection. Therefore, the correct detection and evaluation of HER2 gene expression has important value for clinical treatment of breast cancer.